»

DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2010 archives
Click here to return to the current data set

DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.

Generic Name: selegiline hydrochloride

Summary for Generic Name: selegiline hydrochloride

Tradenames:3
Patents:2
Applicants:12
NDAs:15
Drug Master File Entries: see list14
Suppliers: see list2
Therapeutic Class:Antiparkinson Agents

Pharmacology for Ingredient: selegiline hydrochloride

Clinical Trials for: selegiline hydrochloride

Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Status: Completed Condition: Parkinson's Disease

Evaluation of Adhesion and Dermal Tolerability of EMSAM
Status: Completed Condition: Healthy

PK Comparison of 6mg and 12mg EMSAM in Elderly vs. Non-Elderly
Status: Completed Condition: Healthy

Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression
Status: Completed Condition: Mental Health; Major Depressive Disorder

Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1
Status: Completed Condition: Marijuana Abuse

Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists
Status: Completed Condition: Parkinson's Disease

Effectiveness of the Selegiline Patch in Treating Nicotine Dependent Individuals
Status: Active, not recruiting Condition: Tobacco Use Disorder

Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients
Status: Completed Condition: Cognition Disorders; HIV Infections

Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior
Status: Recruiting Condition: Cocaine Use Disorders

Usefulness of Selegiline as an Aid to Quit Smoking - 1
Status: Active, not recruiting Condition: Tobacco Use Cessation

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist_Flag Patent Expiration Patented / Exclusive Use
Somerset
ELDEPRYL
selegiline hydrochloride
CAPSULE; ORAL020647May 15, 1996RXYes<disabled>
Aaipharma Llc
SELEGILINE HYDROCHLORIDE
selegiline hydrochloride
CAPSULE; ORAL075145Sep 15, 2003DISCNNo<disabled>
Apotex
SELEGILINE HYDROCHLORIDE
selegiline hydrochloride
CAPSULE; ORAL075321Dec 4, 1998RXNo<disabled>
Dava Pharms Inc
SELEGILINE HYDROCHLORIDE
selegiline hydrochloride
CAPSULE; ORAL075352Nov 30, 1998RXNo<disabled>
The preview shows a limited data set. Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Sign up for a free trial

No commitment, no credit card required
First name
Last name
Email address

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639


`abc